BMS 6081 Pill - pink oval
Generic Name: glipizide/metformin
Pill with imprint BMS 6081 is Pink, Oval and has been identified as Metaglip 2.5 mg / 250 mg. It is supplied by Bristol-Myers Squibb.
Metaglip is used in the treatment of Diabetes, Type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. Metaglip 2.5 mg / 250 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for BMS 6081
Metaglip
- Generic Name
- glipizide/metformin
- Imprint
- BMS 6081
- Strength
- 2.5 mg / 250 mg
- Color
- Pink
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- Antidiabetic combinations
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Bristol-Myers Squibb
- National Drug Code (NDC)
- 00087-6081 (Discontinued)
More about Metaglip (glipizide / metformin)
- Check interactions
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: antidiabetic combinations
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
